FdaApplication

BLA 761457

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAmneal Pharmaceuticals LLC
application_typeBLA
approval_date2025-12-19

Products (1)

ProductActive ingredientStrengthDosage form
OZILTUSDENOSUMAB-MOBZ120MG/1.7ML (70MG/ML)Injection

1 product